Using data science to cure cancer topic of Distinguished Lecture

William Dalton is using data to find a cure for cancer. Dalton, PhD, MD, is executive chair and founder of M2GEN, a national biotechnology subsidiary of the Moffitt Cancer Center, Tampa, Florida, whose mission is to connect patients to a cure by accelerating the discovery and delivery of precision medicine. Dalton shared his vision of moving from reactive to proactive medicine through data science as the speaker at last week’s University of Illinois…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following studies have recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about the study, please email cancertrials@uic.edu or call 312-355-5112. Genomically-Guided Treatment Trial in Brain Metastases Sponsor: Alliance for Clinical Trials in Oncology Principal Investigator: Stefania Maraka, MD Phase II Trial of Androgen…

Continue Reading

Funding opportunities

The Respiratory Health Association (RHA) is offering grants for Idiopathic Pulmonary Fibrosis ($25,000) and lung cancer ($50,000). The grants are typically awarded to researchers at health care institutions, and often the funding opportunities help an early-career researcher generate data that he/she can then use to apply for National Institutes of Health or other funding. Applications are due by 5 p.m. (Central Standard Time) Jan.6, 2020. Awards are anticipated to be announced on June…

Continue Reading

New ad campaign educating public on clinical trial diversity

The Center for Information and Study on Clinical Research Participation (CISCRP) has developed a new advertising campaign to educate diverse communities about clinical research and how participating in clinical trials is critical to discovering new treatments for everyone. The full-page advertisement has been published in five different diverse newspapers – both print and digital – in major cities across the United States reaching more than one million individuals in the Black, African American,…

Continue Reading

Kitajewski selected as interim Director of University of Illinois Cancer Center

We are pleased to announce that Jan Kitajewski, PhD has agreed to serve as the Interim Director of the University of Illinois Cancer Center effective December 16, 2019, pending approval of the University of Illinois Board of Trustees. Dr. Kitajewski’s experience as an academic leader, cancer researcher and esteemed member of the Cancer Center community makes him an outstanding individual to lead these efforts during this time of transition. Dr. Kitajewski is currently…

Continue Reading

New paper shows differences in location

University of Illinois Cancer Center member Greg Calip served as co-author on a new study that showed regional differences in improved survival of patients with de novo metastatic breast cancer over time. The work was published in the journal Cancer. Calip, PharmD, MPH, PhD, and his colleagues studied patients in the Surveillance, Epidemiology, and End Results (SEER) 9 population and an institutional cohort with de novo metastatic breast cancer (MBC), which is a…

Continue Reading

Despite fighting metastatic cancer, Rose feeling blessed

  “Truly blessed.” That response may seem unusual from someone who is battling a rare form of cancer, but that’s how Verna Rose feels. “My family’s support has been unbelievable,” said Rose, who more than two years ago was diagnosed with appendiceal carcinoma, a type of cancer that is so rare that it affects only about 10 people per 1 million. “My daughter (Ry AnnElise) gave up her job to take care of…

Continue Reading

Dalton headlining Distinguished Lecture Series

William S. (Bill) Dalton will be the featured speaker at the University of Illinois Cancer Center’s Distinguished Lecture Series on Thursday, Nov. 21, from 1:30 p.m. to 2:30 p.m. in the UIC College of Medicine Research Building’s Moss Auditorium (Room 1020), 909 S. Wolcott Ave. Dalton will present “Moving from Reactive to Proactive Medicine Through Data Science and Collective Impact.” Dalton, PhD, MD, is founder and executive chair of M2Gen, a national biotechnology…

Continue Reading

UI Cancer Center well represented at NCPF

Big data is being used in countless ways today: Dating, shopping, and regulating energy consumption, just to name a few ways. Now add cancer research. The National Cancer Policy Forum recently held a workshop for leading health care professionals to exchange ideas about how big data can be applied to address the social determinants in oncology and develop opportunities to improve health and reduce disparities. Robert Winn, MD, director of the University of…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about the study, please email cancertrials@uic.edu or call 312-355-5112. A Phase II Study of Olaparib and Durvalumab in Men with Castration Sensitive Biochemically Recurrent Non-Metastatic Prostate Cancer Harboring Mutations in DNA Damage…

Continue Reading